The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.
June 13, 2023 at 12:59AM
from Times of India
https://ift.tt/0PQkGZ1
Phase-3 trials find 1-shot chikungunya vaccine safe: Lancet
Subscribe to:
Post Comments (Atom)
Is chewing food linked with a long and healthy life?
Chewing food thoroughly is crucial for digestion, nutrient absorption, and overall health. While the ideal number of chews varies, aiming fo...
-
Several notable WWE veterans passed away in 2024, including Sika Anoa'i, Francisco Ciatso, Akebono, Ole Anderson, and Virgil. These wres...
-
A potential collision was averted at Delhi's IGIA when an Indian carrier's A320, arriving from Phuket, slowed down and failed to pro...
-
Horoscope Today: Read daily horoscope predictions for December 7, 2024. Know all about the astrological events and influences that will be a...
No comments:
Post a Comment